Corrigendum to �Targeted gold nanoparticles enable molecular CT imaging of head and neck cancer: An in vivo study� (International Journal of Biochemistry and Cell Biology (2019) 114, (S1357272519301256), (10.1016/j.biocel.2019.06.002))

The authors would like to highlight that the first 3 figures in this article show data that is either identical or similar to that reported in our previous paper published in Materials Science and Engineering: C 89, 182�193. These figures have been reproduced with permission from Elsevier and were included in response to recommendations received from the both referees who reviewed our manuscript to include characterization data on the structure of the nanoparticles used. © 2019 Elsevier Lt

Incidence, mortality, and burden of hepatitis B and C and geographical distribution in Iran during 2008-2015

Background: This study aimed at estimating the incidence, mortality, and burden of Hepatitis B (HBV) and Hepatitis C (HCV) viruses and their trends from 2008 to 2015. Methods: The Disability Adjusted Life Year (DALYs) index was applied to calculate the burden of the diseases by age, sex, time, and locations. The incidence and demographic data were obtained from HBV and HCV surveillance system, and the data on natural history was extracted from the cohort studies; moreover, the data on the standard life expectancy was obtained from the Iranian life table 2016. The two values of 0.03 and 21.5 yr were set as the discount rate and mean standard duration of the disease for both types of hepatitis. Results: The burden of HBV decreased from 13735 to 78277.6 yr, but there was an increase in the burden of HCV from 5174 to 14395 yr over the studied period. The burden of both types of hepatitis was higher among males than females. The incidence of HBV increased from 46611 to 22996 cases, and the incidence of HCV increased from 1210 to 3939 cases. The HBV decreased from 1925 to 1394 cases; however, the number of deaths caused by HCV increased from 197 to 583 cases over the studied period. The share of YLLs raised from 5 to 10 for HBV whereas it changed from 23 to 62 for HCV over the studied years. Tehran, Khorasan Razavi, and Golestan had the highest and Chaharmahal and Bakhtiari, Kurdistan, and Kermanshah had the lowest adjusted burden of HBV per 1000 population. Conclusion: Although the incidence, mortality, and burden of HBV declined over the eight studied years, these values increased dramatically for HCV. © 2019, Iranian Journal of Public Health. All rights reserved

Frequency and clinical patterns of stroke in Iran - Systematic and critical review

<p>Abstract</p> <p>Background</p> <p>Cerebrovascular disease is the second commonest cause of death, and over a third of stroke deaths occur in developing countries. To fulfil the current gap on data, this systematic review is focused on the frequency of stroke, risk factors, stroke types and mortality in Iran.</p> <p>Methods</p> <p>Thirteen relevant articles were identified by keyword searching of PubMed, Iranmedex, Iranian University index Libraries and the official national data on burden of diseases.</p> <p>Results</p> <p>The publication dates ranged from 1990 to 2008. The annual stroke incidence of various ages ranged from 23 to 103 per 100,000 population. This is comparable to the figures from Arab Countries, higher than sub-Saharan Africa, but lower than developed countries, India, the Caribbean, Latin America, and China. Similarly to other countries, ischaemic stroke was the commonest subtype. Likewise, the most common related risk factor is hypertension in adults, but cardiac causes in young stroke. The 28-day case fatality rate is reported at 19-31%.</p> <p>Conclusions</p> <p>Data on the epidemiology of stroke, its pattern and risk factors from Iran is scarce, but the available data highlights relatively low incidence of stroke. This may reflect a similarity towards the neighbouring nations, and a contrast with the West.</p

Enabling demand response for optimal deployment of multi-carrier microgrids incorporating incentives

Customer multi-carrier microgrid deployments' techno-economic viability and assists investors in deciding whether or not to invest in multi-carrier microgrid installations equipped with smart demand-side technologies are inspected here. The solution of the proposed model determines the optimal mix and size of distributed energy resources, and identifies the ideal participation rate of potential responsive customers within the multi-carrier microgrid. The objective of the proposed model is to minimize the overall deployment cost comprising the investment and replacement of distributed energy resources, demand-side smart measurement and informing appliances, loan payoff, operation, maintenance, peak demand charge, energy demand shifting reward or penalty, emission, and unserved energy while ensuring the desired levels of reliability and online reserve. The model also considers incentive policies to encourage customers to install demand-side smart technologies to participate in demand response programs actively. The planning problem is formulated by mixed-integer programming. The proposed model is applied to an industrial zone as an aggregate load. Numerical simulations exhibit the model's efficacy and scrutinize in-depth, the effect of a variety of factors on multi-carrier microgrid planning results, including the extents of the capital investment fund and loan in addition to demand response enabling technology cost

Side Effects of Intravenous Streptokinase in Different Age Groups Patients with Acute Myocardial Infarction

Abstract Background & aim: Myocardial infarction is one of the most common cardiovascular diseases. Streptokinase is used in patients with myocardial infarction with ST-segment elevation. The aim of this study was to compare the side effects of intravenous streptokinase in acute myocardial infarction patients in different age groups. Methods: In the present analytic descriptive study, the samples included 100 eligible patients which received intravenous streptokinase. The research instrument was a questionnaire consisting of two parts: the first part was used to measure the underlying data and the second part to evaluate the side effects of intravenous streptokinase,. Data were analyzed by chi-square statistical tests. Results: There were no significant adverse events between intravenous streptokinase and different age groups ((P>0.05).). The most common side effects of this drug were cardiovascular complications in different age groups. Conclusion: the use of streptokinase intravenous drug in different age groups is associated with risk of cardiovascular complications. Key words: age, side effects, streptokinase, acute myocardial infarction, thrombolytic therapy, ST elevatio

Designing Adaptive Nonlinear Controller for Optimal Tracking of Laparoscopic Robotic Arm with Nonholonomic Constraints

Laparoscopic surgery is one kind of minimally invasive surgery in which surgeons can control and evaluate the tracking of the robot via special monitoring. Preserving stability, precise tracking, and uncertainties estimation are essential factors in controller design for these systems. Designing autonomous graspers would improve the perception of surgeons and reduce the unwanted errors of operations. An adaptive inverse dynamic controller is proposed in this paper to improve the performance of the tracking desired trajectories for gripper of the surgical robots used in laparoscopic surgeries. By considering nonholonomic conditions for the grasper of the robot, the workspace is generalized, and using the Ritz approximation method, the optimal steering problem for nonholonomic gripper has been solved. In this case, the surgeon can steer the gasper of the surgical robot from any initial condition to any desired destination point. The performance of the proposed controller for nonholonomic conditions is demonstrated by simulation results